+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report By Animal Type (Companion, Livestock), By Route Of Administration, By Indication, By Distribution Channel, By Region, and Segment Forecasts, 2021-2028

  • PDF Icon

    Report

  • 150 Pages
  • October 2021
  • Region: Global
  • Grand View Research
  • ID: 5457626
The global veterinary dermatology drugs market size is anticipated to reach USD 14.6 billion by 2028. The market is expected to expand at a CAGR of 9.3% from 2021 to 2028. Increasing incidences of dermatology diseases such as fleas and ticks and allergic dermatitis are expected to boost the market growth. Furthermore, a growing number of clinical trials related to veterinary dermatology drugs is also anticipated to fuel market growth.





Due to the COVID-19 pandemic, some market players such as experience no negative impact. For instance, Elanco experienced a growth of 6.6% in its annual revenue. Also, Vetoquinol and Zoetis reported a growth of 8% and 6.6% in their annual revenue, respectively. On the other hand, Virbac reported a decline of 0.4% in its total revenue and a 6.9% decline in its companion animal parasiticides and dermatology segment as well as bovine parasiticides segment. This neutralized the impact of COVID-19 on the market.

Growth in the companion animal population is expected to increase the demand for veterinary healthcare products, such as dermatology drugs, and boost the overall expenditure on pets. According to the American Pet Products Association report, overall spending in the U.S. pet industry was USD 95.7 Billion in 2019 and forecast to reach approximately USD 99 Billion in 2020. Veterinary care spending increased by 560% between 1994 and 2019.

The market for veterinary dermatology drugs is fairly competitive. The most notable participants in the market are Zoetis, Virbac, and Elanco, along with other manufacturers. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in March 2021, Virbac obtained the rights to certain early-stage parasiticides products from Elanco, hence expanding its product portfolio. Also, in February 2021, Vetoquinol acquired the rights from Elanco for the Profender product family comprising of topical dewormer products, for the market in Canada. This expanded its geographical presence.

Veterinary Dermatology Drugs Market Report Highlights

  • The companion animal segment held the dominant share of more than 70.0% in the animal type segment as of 2020 owing to the high pet ownership rate.
  • The oral segment held the largest market share of the route of administration segment as of 2020, accounting for more than 37.0% of the revenue share, owing to its easy availability.
  • The parasitic infections segment held the largest market share of the indication segment as of 2020, owing to a high prevalence of parasitic infections.
  • The hospital pharmacies segment held the largest market share of 42.4% in 2020 in the distribution channel segment.
  • In 2020, North America held the dominant share of the market owing to the increasing pet care expenditure.
  • In Asia Pacific, the market is expected to show lucrative growth over the forecast period owing to the growing demand for veterinary dermatology drugs in the region.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Veterinary Dermatology Drugs Market

What is the estimated value of the Global Veterinary Dermatology Drugs Market?

The Global Veterinary Dermatology Drugs Market was estimated to be valued at $7.9 billion in 2021.

What is the growth rate of the Global Veterinary Dermatology Drugs Market?

The growth rate of the Global Veterinary Dermatology Drugs Market is 9.2%, with an estimated value of $14.6 billion by 2028.

What is the forecasted size of the Global Veterinary Dermatology Drugs Market?

The Global Veterinary Dermatology Drugs Market is estimated to be worth $14.6 billion by 2028.

Who are the key companies in the Global Veterinary Dermatology Drugs Market?

Key companies in the Global Veterinary Dermatology Drugs Market include Elanco, Vetoquinol S.A., Ceva, Merck & Co., Inc., Zoetis, Virbac, Bimeda, Inc., Vivaldis and Indian Immunologicals Ltd.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Workflow Analysis (Model 1)
1.7 List Of Primary Sources
1.8 List Of Secondary Sources
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Veterinary Dermatology Drugs Market Outlook, 2016 - 2028 (USD Million)
2.2 Veterinary Dermatology Drugs Market Summary, 2020
2.3 Segment Outlook
Chapter 3 Veterinary Dermatology Drugs Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Veterinary Dermatology Drugs Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing Pet Ownership
3.3.1.2 Growing Number Of Clinical Trials Related To Veterinary Dermatology Drugs
3.3.1.3 Rising Incidence Rate Of Parasitic As Well As Other Skin Diseases In Animals
3.3.1.4 Investments By Market Players
3.3.2 Market Restraint Analysis
3.3.2.1 Lack Of Awareness In Developing Regions
3.3.2.2 Disease Outbreaks
3.3.3 Opportunities
3.3.4 Challenges
3.4 Veterinary Dermatology Drugs Market Analysis Tools: Porters
3.4.1 Supplier Power: Low
3.4.2 Buyer Power: Moderate To High
3.4.3 Threat Of Substitutes: Low
3.4.4 Threat Of New Entrants: Moderate
3.4.5 Competitive Rivalry: High
3.5 Veterinary Dermatology Drugs Market Analysis Tools: Pestel Analysis
3.5.1 Political Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.5.5 Legal Landscape
3.6 Clinical Trial Analysis
3.7 Consumer Preference Matrix
3.8 Regulatory Landscape
Chapter 4 Impact Of Covid-19 On Veterinary Dermatology Drugs Market
4.1. Disease Prevalence Analysis
4.2. Current And Future Impact Analysis
4.3. Impact Of Covid-19 On Market Players
Chapter 5 Veterinary Dermatology Drugs Market: Animal Type Estimates & Trend Analysis
5.1 Veterinary Dermatology Drugs Market: Animal Type Movement Analysis
5.2 Companion Animal
5.2.1 Companion Animal Market Estimates And Forecasts, 2016 - 2028 (USD Million)
5.3 Livestock Animal
5.3.1 Livestock Animal Market Estimates And Forecasts, 2016 - 2028 (USD Million)
Chapter 6 Veterinary Dermatology Drugs Market: Route Of Administration Estimates & Trend Analysis
6.1 Veterinary Dermatology Drugs Market: Route Of Administration Movement Analysis
6.2 Oral
6.2.1 Oral Market Estimates And Forecasts, 2016 - 2028 (USD Million)
6.3 Topical
6.3.1 Topical Market Estimates And Forecasts, 2016 - 2028 (USD Million)
6.4 InjecTable
6.4.1 InjecTable Market Estimates And Forecasts, 2016 - 2028 (USD Million)
Chapter 7 Veterinary Dermatology Drugs Market: Indication Estimates & Trend Analysis
7.1 Veterinary Dermatology Drugs Market: Indication Movement Analysis
7.2 Parasitic Infections
7.2.1 Parasitic Infections Market Estimates And Forecasts, 2016 - 2028 (USD Million)
7.3 Allergic Infections
7.3.1 Allergic Infections Market Estimates And Forecasts, 2016 - 2028 (USD Million)
7.4 Others
7.4.1 Others Market Estimates And Forecasts, 2016 - 2028 (USD Million)
Chapter 8 Veterinary Dermatology Drugs Market: Distribution Channel Estimates & Trend Analysis
8.1 Veterinary Dermatology Drugs Market: Distribution Channel Movement Analysis
8.2 Retail
8.2.1 Retail Market Estimates And Forecasts, 2016 - 2028 (USD Million)
8.3 E-Commerce
8.3.1 E-Commerce Market Estimates And Forecasts, 2016 - 2028 (USD Million)
8.4 Hospital Pharmacies
8.4.1 Hospital Pharmacies Market Estimates And Forecasts, 2016 - 2028 (USD Million)
Chapter 9 Veterinary Dermatology Drugs Market: Regional Estimates & Trend Analysis
9.1 Veterinary Dermatology Drugs Market Shares By Region, 2020 & 2028
9.2 North America
9.2.1 North America Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.3.2 U.K.
9.3.2.1 U.K. Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.3.3 Germany
9.3.3.1 Germany Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.3.5 Spain
9.3.5.1 Spain Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.3.6 Italy
9.3.6.1 Italy Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.4.3 South Korea
9.4.3.1 South Korea Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.4.4 China
9.4.4.1 China Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.4.5 India
9.4.5.1 India Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.4.6 Australia
9.4.6.1 Australia Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.5.4 Argentina
9.5.4.1 Argentina Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.6 MEA
9.6.1 MEA Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Veterinary Dermatology Drugs Market Estimates And Forecasts, 2016 - 2028 (USD Million)
Chapter 10 Veterinary Dermatology Drugs Market Competitive & Vendor Landscape
10.1 Participation Categorization
10.2 Competitive Dashboard Analysis
10.3 Public Companies
10.3.1 Company Market Position Analysis
10.3.2 Heat Map Analysis
10.4 Private Companies
10.4.1 Heat Map Analysis
10.5 Detailed List Of Market Players
Chapter 11 Company Profiles
11.1 Elanco
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 Vetoquinol S.A.
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 Ceva
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Merck & Co., Inc.
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 Zoetis
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 Virbac
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 Bimeda, Inc.
11.7.1 Company Overview
11.7.2 Product Benchmarking
11.7.3 Financial Performance
11.7.4 Strategic Initiatives
11.8 Vivaldis
11.8.1 Company Overview
11.8.2 Product Benchmarking
11.8.3 Financial Performance
11.8.4 Strategic Initiatives
11.9 Bioiberica S.A.U
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 Indian Immunologicals Ltd
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.10.4 Strategic Initiatives
List of Tables
Table 1 Primary interview details: North America
Table 2 Primary interview details: Europe
Table 3 Primary interview details: Asia Pacific
Table 4 Primary interview details: Latin America
Table 5 Primary interview details: Middle East and Africa
Table 6 List of secondary sources
Table 7 List of key companies
Table 8 North America Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 9 North America Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 10 North America Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 11 North America Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 12 U.S. Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 13 U.S. Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 14 U.S. Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 15 U.S. Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 16 Canada Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 17 Canada Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 18 Canada Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 19 Canada Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 20 Europe Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 21 Europe Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 22 Europe Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 23 Europe Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 24 U.K. Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 25 U.K. Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 26 U.K. Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 27 U.K. Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 28 Germany Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 29 Germany Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 30 Germany Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 31 Germany Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 32 France Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 33 France Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 34 France Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 35 France Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 36 Italy Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 37 Italy Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 38 Italy Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 39 Italy Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 40 Spain Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 41 Spain Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 42 Spain Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 43 Spain Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 44 Asia Pacific Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 45 Asia Pacific Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 46 Asia Pacific Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 47 Asia Pacific Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 48 Japan Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 49 Japan Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 50 Japan Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 51 Japan Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 52 South Korea Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 53 South Korea Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 54 South Korea Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 55 South Korea Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 56 China Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 57 China Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 58 China Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 59 China Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 60 India Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 61 India Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 62 India Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 63 India Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 64 Australia Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 65 Australia Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 66 Australia Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 67 Australia Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 68 Latin America Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 69 Latin America Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 70 Latin America Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 71 Latin America Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 72 Brazil Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 73 Brazil Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 74 Brazil Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 75 Brazil Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 76 Mexico Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 77 Mexico Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 78 Mexico Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 79 Mexico Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 80 Argentina Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 81 Argentina Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 82 Argentina Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 83 Argentina Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 84 MEA Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 85 MEA Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 86 MEA Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 87 MEA Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 88 South Africa Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 89 South Africa Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 90 South Africa Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 91 South Africa Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
Table 92 SA Veterinary dermatology drugs market, by animal type, 2016-2028 (USD Million)
Table 93 SA Veterinary dermatology drugs market, by route of administration, 2016-2028 (USD Million)
Table 94 SA Veterinary dermatology drugs market, by Indication, 2016-2028 (USD Million)
Table 95 SA Veterinary dermatology drugs market, by Distribution Channel, 2016-2028 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity workflow analysis
Fig. 10 Veterinary dermatology drugs market revenue, 2016-2028 (USD Million)
Fig. 11 Veterinary dermatology drugs market snapshot, 2020 (USD Million)
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Penetration & growth prospect mapping by Animal Type, 2020
Fig. 15 Veterinary dermatology drugs market dynamics
Fig. 16 Veterinary dermatology drugs market driver impact
Fig. 17 Veterinary dermatology drugs market restraint impact
Fig. 18 COVID-19 disease prevalence
Fig. 19 Market Participant Categorization
Fig. 20 Competitive dashboard analysis
Fig. 21 Company market position analysis
Fig. 22 Heat map analysis
Fig. 23 Veterinary dermatology drugs market Animal Type outlook: Key takeaways
Fig. 24 Veterinary dermatology drugs market: Animal Type movement analysis
Fig. 25 Global companion animal market, 2016-2028 (USD Million)
Fig. 26 Global livestock animal market, 2016-2028 (USD Million)
Fig. 27 Veterinary dermatology drugs market: Route of administration movement analysis
Fig. 28 Veterinary dermatology drugs market: Route of administration outlook: Key takeaways
Fig. 29 Global Oral market, 2016-2028 (USD Million)
Fig. 30 Global topical market, 2016-2028 (USD Million)
Fig. 31 Global InjecTable market, 2016-2028 (USD Million)
Fig. 32 Veterinary dermatology drugs market: Indication movement analysis
Fig. 33 Veterinary dermatology drugs market: Indication outlook: Key takeaways
Fig. 34 Global Parasitic Infections market, 2016-2028 (USD Million)
Fig. 35 Global Allergic Infections market, 2016-2028 (USD Million)
Fig. 36 Global others market, 2016-2028 (USD Million)
Fig. 37 Veterinary dermatology drugs market: Distribution Channel movement analysis
Fig. 38 Veterinary dermatology drugs market: Distribution Channel outlook: Key takeaways
Fig. 39 Global Retail market, 2016-2028 (USD Million)
Fig. 40 Global E-Commerce market, 2016-2028 (USD Million)
Fig. 41 Global hospital pharmacies market, 2016-2028 (USD Million)
Fig. 42 Regional marketplace: Key takeaways
Fig. 43 Regional outlook, 2020 & 2028
Fig. 44 North America Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 45 U.S. Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 46 Canada Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 47 Europe Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 48 U.K. Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 49 Germany Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 50 France Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 51 Spain Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 52 Italy Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 53 Asia Pacific Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 54 Japan Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 55 South Korea Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 56 China Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 57 India Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 58 Australia Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 59 Latin America Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 60 Brazil Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 61 Mexico Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 62 Argentina Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 63 MEA Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 64 South Africa Veterinary dermatology drugs market, 2016-2028 (USD Million)
Fig. 65 Saudi Arabia Veterinary dermatology drugs market, 2016-2028 (USD Million)

Companies Mentioned

  • Elanco
  • Vetoquinol S.A.
  • Ceva
  • Merck & Co., Inc.
  • Zoetis
  • Virbac
  • Bimeda, Inc.
  • Vivaldis
  • Bioiberica S.A.U
  • Indian Immunologicals Ltd

Methodology

Loading
LOADING...